It was a strong day for pharmaceutical company Merck on Wednesday. The stock’s shares started to fly after it was upgraded by Citi analysts from “neutral” to “buy.” The analysts noted that stronger sales from the company’s Keytruda drug, an immunotherapy used in cancer treatments, are expected. Along with the upgrade, the firm also upped … Continue reading “Merck Shares Explode After Citi Upgrade”
